Lupin Ltd (LUPIN) - Financial and Strategic SWOT Analysis Review

Lupin Ltd (LUPIN) - Financial and Strategic SWOT Analysis Review

  • Products Id :- GDPH61242FSA
  • |
  • Pages: 57
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Lupin Ltd (LUPIN)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


Lupin Ltd (Lupin) focuses on the development and manufacture of generic and branded formulations, biotechnology products and active pharmaceutical ingredients (APIs). The company has expertise in the areas of cardiovascular, asthma, diabetology, pediatrics, central nervous system, gastro-intestinal, anti-infectives, nonsteroidal anti-inflammatory drugs (NSAIDs), anti-TB and cephalosporins. It undertakes extensive research and development of pharmaceuticals for treatment of migraine, gastrointestinal, psoriasis, central nervous system, cardiovascular, tuberculosis, diabetes and inflammation. Lupin develops value-added generic pharmaceuticals based on its platform technologies. The company along with its subsidiaries has manufacturing facilities in India, the US, Japan, Mexico and Brazil. Lupin is headquartered in Mumbai, Maharashtra, India.

Lupin Ltd Key Recent Developments

Jul 16,2018: Lupin's Goa facility gets approval from UK MHRA

Jul 10,2018: Lupin appoints Yashwant Mahadik as President-Global HR

Jul 05,2018: Trend Micro secures Lupin's vast IT environment

Jun 29,2018: Lupin announces tie-up with European Association of Urology (EAU)

May 31,2018: Lupin appoints Nicholas Hart as President-Specialty for US Business

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Lupin Ltd-Key Facts 6

Lupin Ltd-Key Employees 7

Lupin Ltd-Key Employee Biographies 9

Lupin Ltd-Major Products and Services 10

Lupin Ltd-History 11

Lupin Ltd-Company Statement 19

Lupin Ltd-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Joint Venture 23

Section 2-Company Analysis 24

Company Overview 24

Lupin Ltd-Business Description 25

R&D Overview 25

Lupin Ltd-Corporate Strategy 26

Lupin Ltd-SWOT Analysis 27

SWOT Analysis-Overview 27

Lupin Ltd-Strengths 27

Lupin Ltd-Weaknesses 28

Lupin Ltd-Opportunities 29

Lupin Ltd-Threats 30

Lupin Ltd-Key Competitors 31

Section 3-Company Financial Ratios 32

Financial Ratios-Capital Market Ratios 32

Financial Ratios-Annual Ratios 33

Performance Chart 36

Financial Performance 36

Financial Ratios-Interim Ratios 37

Financial Ratios-Ratio Charts 38

Section 4-Company's Lifesciences Financial Deals and Alliances 39

Lupin Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 39

Lupin Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 40

Lupin Ltd, Recent Deals Summary 41

Section 5-Company's Recent Developments 42

Jul 16, 2018: Lupin's Goa facility gets approval from UK MHRA 42

Jul 10, 2018: Lupin appoints Yashwant Mahadik as President-Global HR 43

Jun 29, 2018: Lupin announces tie-up with European Association of Urology (EAU) 44

May 31, 2018: Lupin appoints Nicholas Hart as President-Specialty for US Business 45

May 15, 2018: Lupin announces fiscal year 2018 Results, Board recommends dividend of 250% 46

May 14, 2018: Lupin's Nagpur facility US FDA inspection concluded with no observations 48

May 10, 2018: Lupin launches Corcal Bone and Beauty supplement 49

Apr 09, 2018: Lupin's Softovac in The Economic Times 'Promising Brands of 2018' 50

Apr 09, 2018: Lupin's Softovac In Economic Times 'Promising Brands Of 2018 51

Apr 06, 2018: Lupin's Pithampur Unit 1 facility receives Establishment Investigation report (EIR) from US FDA 52

Section 6-Appendix 53

Methodology 53

Ratio Definitions 53

About GlobalData 57

Contact Us 57

Disclaimer 57

List of Figures

Lupin Ltd, Performance Chart (2014-2018) 36

Lupin Ltd, Ratio Charts 38

Lupin Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 39

Lupin Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 40

List of Tables

Lupin Ltd, Key Facts 6

Lupin Ltd, Key Employees 7

Lupin Ltd, Key Employee Biographies 9

Lupin Ltd, Major Products and Services 10

Lupin Ltd, History 11

Lupin Ltd, Other Locations 20

Lupin Ltd, Subsidiaries 20

Lupin Ltd, Joint Venture 23

Lupin Ltd, Key Competitors 31

Lupin Ltd, Ratios based on current share price 32

Lupin Ltd, Annual Ratios 33

Lupin Ltd, Annual Ratios (Cont...1) 34

Lupin Ltd, Annual Ratios (Cont...2) 35

Lupin Ltd, Interim Ratios 37

Lupin Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 39

Lupin Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 40

Lupin Ltd, Recent Deals Summary 41

Currency Codes 53

Capital Market Ratios 53

Equity Ratios 54

Profitability Ratios 54

Cost Ratios 55

Liquidity Ratios 55

Leverage Ratios 56

Efficiency Ratios 56

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Sun Pharmaceutical Industries Ltd

Lincon Pharmaceuticals Ltd

Intas Pharmaceuticals Ltd

Dr. Reddy's Laboratories Ltd

Divi's Laboratories Ltd

Cipla Ltd

Abbott India Ltd

Aarti Drugs Ltd

Lupin Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8750
Site License
USD 250 INR 17500
Corporate User License
USD 375 INR 26250



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]